Investment
Features
FeesSafety
Academy
More
Pluang+

Compare British American Tobacco PLC (BTI) vs F5 Inc (FFIV) Price & Performance

British American Tobacco PLCTrade
F5 IncTrade

Price performance (Past 24H)

Key statistics

British American Tobacco PLC vs F5 Inc — how do they compare? British American Tobacco PLC trades at $58.58 (market cap $124.84B), while F5 Inc trades at $433.94 (market cap $24.33B). The key difference: British American Tobacco PLC is far larger — about 5.1× F5 Inc's market cap, and British American Tobacco PLC pays a 5.74% dividend while F5 Inc pays none. Which is the better fit depends on your goals.

BTIFFIV
Market Cap
$124.84B$24.33B
Sector
Consumer StaplesTechnology
52-Week High
$66.70$431.26
52-Week Low
$50.39$223.99
Enterprise Value
$166.06B$23.15B
Dividend Yield
5.74%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

British American Tobacco PLC

British American Tobacco (BTI) trades at $58.95, down 1.78% on the day, with mixed technical signals showing bearish moving averages but neutral oscillators. Fundamentally, the company maintains strong profitability with 30.32% net income margin and attractive valuation at 12.79 P/E ratio. Recent earnings show beats in Q2 and Q4 2025, though Q4 2024 missed expectations. The company is undergoing restructuring with 5,500 job cuts announced in June 2026 to streamline operations and reduce costs.

BTI presents a compelling value opportunity with strong dividend yield and improving earnings trajectory, though facing regulatory headwinds and declining cigarette volumes. The stock's current valuation appears attractive relative to historical levels, supported by robust cash flow generation and strategic pivot toward smoke-free products. Key risks include ongoing regulatory pressures and consumer shift away from traditional tobacco products.

F5 Inc

F5 Networks (FFIV) trades at $420.95, down 2.19% today, with a bullish technical signal from moving averages and strong fundamental performance. The company has beaten earnings expectations for three consecutive quarters, with Q1 2026 EPS of $3.90 exceeding the $3.46 estimate. Revenue growth accelerated to $3.09 billion in 2025, while net income margins expanded to 22.42%. Recent strategic moves include expanding AI security capabilities through the SurePath AI acquisition and new executive appointments.

FFIV presents a mixed outlook with strong operational execution offset by premium valuations. The stock trades above analyst consensus target of $397, though institutional sentiment remains positive with 40% buy ratings. Key risks include competitive pressures in cybersecurity and execution challenges in AI integration. Earnings growth and margin expansion remain the primary catalysts for further upside potential.

Returns comparison

Trailing returns across standard periods

About British American Tobacco PLC

Following the acquisition of Reynolds American, British American Tobacco is neck-and-neck with Philip Morris International to be the largest listed global tobacco company--slightly larger than PMI on net revenue, but slightly smaller on total tobacco volume. British American's Global Drive Brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans, and it also owns Newport and Camel in the U.S. The firm also sells vapor e-cigarettes, including its Vype brand, heated tobacco, with Glo, as well as roll- your-own and smokeless tobacco products. The company holds 31% of ITC Limited, the leading Indian cigarette-maker.

Read more on BTI

About F5 Inc

F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.

Read more on FFIV